Study guide

5.3 Intracranial Hemodynamics & Clinical TCD Applications

CCI Registered Vascular Specialist RVS

Track your progress as you read

Finished sections get a check mark.

1 Introduction & Exam Overview

1.1 About the CCI RVS Exam 1.2 How to Prepare for the RVS Exam

2 Principles of Ultrasound Physics & Transducer Technology

2.1 Ultrasound Waves, Propagation Speed & Attenuation 2.2 Transducer Selection & Beam Formation 2.3 Grayscale Instrumentation & B-Mode Optimization

3 Hemodynamics & Doppler Waveform Analysis

3.1 Hemodynamics & Fluid Energy Principles 3.2 The Doppler Equation & Spectral Optimization 3.3 Spectral Waveform & Color Flow Analysis

4 Extracranial Carotid Duplex Evaluation

4.1 Extracranial Cerebrovascular Anatomy & Protocol 4.2 Differentiating ICA vs ECA & Plaque Characterization 4.3 Carotid Velocity Criteria & Stenosis Staging 4.4 Carotid Endarterectomy and Stent Follow-up

5 Vertebral Artery & Intracranial Cerebrovascular Testing

5.1 Vertebral Artery Duplex & Subclavian Steal 5.2 Transcranial Doppler (TCD & TCDI) Principles & Windows 5.3 Intracranial Hemodynamics & Clinical TCD Applications

6 Lower Extremity Peripheral Arterial Physiologic Testing

6.1 Lower Extremity Arterial Anatomy & Clinical Presentation 6.2 Ankle-Brachial Index (ABI) & Toe-Brachial Index (TBI) 6.3 Segmental Pressure Examination 6.4 Pulse Volume Recording (PVR) & Exercise Testing

7 Lower Extremity Arterial Duplex, Bypass & Stent Surveillance

7.1 Lower Extremity Arterial Duplex Protocol 7.2 Arterial Stenosis & Occlusion Diagnostic Criteria 7.3 Bypass Graft Surveillance Protocols & Criteria 7.4 Stent Surveillance, Pseudoaneurysms & Arterial Emergencies

8 Upper Extremity Arterial Testing & Thoracic Outlet Syndrome

8.1 Upper Extremity Arterial Anatomy & Examination Protocol 8.2 Upper Extremity Occlusive Disease & Vasospastic Disorders 8.3 Thoracic Outlet Syndrome (TOS) Evaluation

9 Lower Extremity Deep & Superficial Venous Duplex Evaluation

9.1 Lower Extremity Venous Anatomy & Hemodynamics 9.2 Venous Duplex Protocol for Deep Vein Thrombosis 9.3 Acute vs Chronic DVT Ultrasound Characteristics 9.4 Special Venous Syndromes & Non-Vascular Findings

10 Chronic Venous Insufficiency, Mapping & Reflux Testing

10.1 Pathophysiology of Venous Reflux & CEAP Classification 10.2 Venous Reflux Examination Protocol & Cutoffs 10.3 Saphenous Vein Mapping Protocol & Criteria 10.4 Endovenous Ablation Surveillance & EHIT Classification

11 Upper Extremity Venous Duplex & Central Vein Evaluation

11.1 Upper Extremity Venous Anatomy & Examination Protocol 11.2 Upper Extremity DVT & Effort Thrombosis 11.3 Central Venous Obstruction & Catheter Surveillance

12 Abdominal Aorta, Aneurysms & EVAR Surveillance

12.1 Abdominal Aorta & Iliac Duplex Protocol 12.2 AAA Screening, Growth Rates & Rupture Risk 12.3 Endovascular Aneurysm Repair (EVAR) Surveillance & Endoleaks

13 Visceral Duplex: Renal, Mesenteric & Hepatoportal Systems

13.1 Renal Artery Duplex: Direct Examination & Velocity Criteria 13.2 Renal Artery Duplex: Indirect Intrarenal Waveform Analysis 13.3 Mesenteric Artery Duplex: Celiac, SMA & IMA 13.4 Hepatoportal Hemodynamics & TIPS Surveillance 13.5 Iliocaval Duplex and Venous Stent Assessment 13.6 Kidney and Liver Transplant Vascular Duplex

14 Hemodialysis Access Planning & Surveillance

14.1 Pre-Operative Vascular Mapping for Dialysis Access 14.2 Duplex Evaluation of AV Fistulas & Grafts 14.3 Dialysis Access Complications & Steal Syndrome

15 Patient Care, Safety, Ergonomics & Quality Standards

15.1 Patient Assessment, Clinical Indications & Physical Exam 15.2 Infection Control, Disinfection & Sterile Technique 15.3 Acoustic Bioeffects, ALARA & Safety 15.4 Sonographer Ergonomics & Laboratory Accreditation 15.5 Emergencies, Pharmacology, Ethics and Preliminary Findings

5.3 Intracranial Hemodynamics & Clinical TCD Applications

Key Takeaways Explain This Topic AI

Use the velocity parameter and imaging/non-imaging protocol required by the specific TCD application.

Lindegaard ratio is MCA mean/extracranial ICA mean; interpret it with absolute MCA velocity and clinical context.

Non-imaging STOP categories use TAMMV: <170 normal, 170–199 conditional, and ≥200 cm/s abnormal; confirmation matters.

Contrast TCD detects right-to-left passage but does not independently localize a PFO.

TCD may be an ancillary neurologic-death test in adults under the 2023 guideline; absent signal alone is insufficient and pediatric use is not supported.

Last updated: October 2026

Interpret TCD in the correct protocol

Transcranial Doppler (TCD) measures intracranial blood-flow velocity. It does not directly measure cerebral volume flow, tissue oxygenation, or the exact percentage of every intracranial stenosis. Vessel identification uses the acoustic window, depth, direction, neighboring signals, and compression or other protocol-specific maneuvers where appropriate. Imaging and non-imaging techniques have different acquisition assumptions, so their thresholds must not be mixed.

Record the vessel, side, depth, waveform quality, and the velocity parameter actually measured. Peak systolic velocity , a time-averaged spectral-envelope velocity, and a time-averaged mean across the spectrum are not interchangeable. Published clinical algorithms depend on specific measurements. A number without its parameter and technique can lead to the wrong conclusion.

Vasospasm after subarachnoid hemorrhage

After aneurysmal subarachnoid hemorrhage (aSAH) , TCD trends can help identify vasospasm and support evaluation of delayed cerebral ischemia. Serial studies are more useful when vessel depth, technique, and measurement method are comparable. Increased velocity may reflect narrowing, hyperemia, anemia, systemic changes, or technical differences. Interpret it with the neurological examination and the clinical team's other data.

For the middle cerebral artery (MCA) , commonly used mean-velocity bands are below 120 cm/s, 120–199 cm/s, and at least 200 cm/s, with increasing concern for vasospasm in the appropriate setting. These bands are not transferable to every intracranial artery. A low velocity does not guarantee normal perfusion in a patient with severe disease or poor insonation.

Lindegaard ratio

The Lindegaard ratio compares the MCA mean velocity with the ipsilateral extracranial ICA mean velocity obtained using the appropriate protocol: LR = MCA mean velocity extracranial ICA mean velocity \text{LR} = \frac{\text{MCA mean velocity}}{\text{extracranial ICA mean velocity}} LR = extracranial ICA mean velocity MCA mean velocity ​

A ratio below about 3 favors hyperemia rather than focal MCA vasospasm; ratios 3–6 support vasospasm, and values above 6 are strongly concerning for severe vasospasm when supported by the MCA velocity and clinical context. Use the ratio and absolute velocity together. A high ratio caused by a very low denominator is not an independent proof of severe narrowing.

For MCA mean velocity 195 cm/s and extracranial ICA mean velocity 30 cm/s, LR = 6.5 . This is concerning for vasospasm and requires clinical correlation. The absolute MCA value is below the usual ≥200 severe band, so report the discordance rather than claiming both measurements independently prove a severe grade.

The 2023 AHA/ASA aSAH guideline emphasizes euvolemia . Do not describe routine prophylactic “triple-H therapy” of hypertension, hypervolemia, and hemodilution as the current default. Treatment of symptomatic ischemia is directed by the neurocritical-care team, not by a sonographer's velocity category alone.

Sickle-cell stroke-risk screening

The STOP method uses non-imaging TCD to measure time-averaged maximum velocity (TAMMV) in the distal ICA or proximal MCA. For children with appropriate sickle-cell genotypes, commonly taught categories are normal <170 cm/s , conditional 170–199 cm/s , and abnormal ≥200 cm/s . The parameter is not PSV. Use the validated screening protocol and identify whether the examination is imaging or non-imaging.

The 2020 ASH guideline describes confirmation with two non-imaging values ≥200 cm/s or one value >220 cm/s for the treatment threshold. Imaging TCD uses different thresholds. An abnormal screen triggers specialist evaluation and protocol-directed management; it should not be presented as proof of an exact fixed stenosis or as an automatic transfusion order from one 200 cm/s value.

A child with one non-imaging TAMMV of 205 cm/s has an abnormal screening category. The clinical team confirms and manages the result according to the protocol. A PSV of 205 cm/s, in contrast, cannot be substituted into the TAMMV algorithm. Document the measurement method clearly so the correct pathway is followed.

Collateral pathways and embolic monitoring

With carotid disease, the anterior communicating artery can supply cross-filling, the posterior communicating artery can connect posterior and anterior circulation, and external-to-internal pathways can reverse ophthalmic flow. Direction changes suggest recruitment but must be interpreted with the entire vascular anatomy. A single reversed signal without reliable vessel identification is not adequate evidence of a collateral pathway.

Microembolic signals are brief high-intensity Doppler events that require protocol-based recognition and artifact discrimination. Movement, probe contact, and other noise can mimic emboli. Monitoring duration, insonated vessel, and signal characteristics matter. A contrast TCD right-to-left shunt study can demonstrate microbubble passage but does not by itself locate the shunt or prove that it is a patent foramen ovale rather than another right-to-left pathway. Echocardiographic or other evaluation may be needed.

Cerebral circulatory arrest: the diagnostic boundary

As intracranial perfusion fails, characteristic patterns can include oscillating flow with little net forward flow and brief systolic spikes. Absent signal alone is insufficient , because a poor acoustic window can prevent insonation in a living patient. Technical adequacy and the required anterior/posterior circulation sampling must be established.

The 2023 AAN/AAP/CNS/SCCM guideline allows TCD as an ancillary test for adults when ancillary testing is indicated and performed under the appropriate protocol. It should not be used as an ancillary test for children under that guideline. Brain death/death by neurologic criteria is a clinical determination with prerequisites, examination, and apnea-testing requirements. A sonographer must not equate one abnormal trace with legal death.

When recording a concerning pattern, preserve representative waveforms and communicate promptly to the responsible clinician. State limitations, physiological conditions, and the protocol used. The authority to determine death and the validity of ancillary testing remain with appropriately qualified clinicians and applicable policy.

ASH cerebrovascular guideline , 2023 aSAH guideline , and 2023 neurologic death guideline — checked October 18, 2026.

Match the measurement to the question

Application Required context Common interpretation trap

MCA vasospasm surveillance Mean velocity, Lindegaard ratio, serial trend, neurologic findings Calling every elevated velocity vasospasm

Non-imaging STOP screening TAMMV in the specified vessels and confirmation protocol Substituting PSV or an imaging-TCD threshold

Contrast shunt assessment Protocol-controlled microbubble monitoring Assuming detected right-to-left passage locates a PFO

Adult ancillary circulatory assessment Qualified protocol and clinical prerequisites Treating an absent signal as proof of death